NCT04412902View on ClinicalTrials.gov

Predictors of Recurrence for High Risk Endometrial Cancer Patients

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

April 25, 2020

Primary Completion Date

October 25, 2020

Study Completion Date

November 25, 2020

Conditions
High-risk Endometrial Cancer
Interventions
DRUG

adjuvant therapy

Adjuvant chemotherapy and/or radiotherapy

Trial Locations (1)

22050

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER

NCT04412902 - Predictors of Recurrence for High Risk Endometrial Cancer Patients | Biotech Hunter | Biotech Hunter